Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Parathyroid Neoplasms 1Neovascularization, Pathologic 1Hyperparathyroidism, Primary 1Carcinoma, Renal Cell 1

Interventions

Specimen Handling 8Nivolumab 7pembrolizumab 4lenvatinib 3cabozantinib 3Ipilimumab 3Biopsy 3Axitinib 3vorolanib 2fludarabine 2anlotinib 2Sunitinib 2Nephrectomy 2Magnetic Resonance Spectroscopy 2Cyclophosphamide 2CTLA-4 Antigen 2toripalimab 1tivozanib 1sodium-iodide symporter 1sintilimab 1pazopanib 1fludarabine phosphate 1enzalutamide 1cemiplimab 1bemarituzumab 1belzutifan 1balstilimab 1atezolizumab 1abiraterone 1Zoledronic Acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × Carcinoma, Renal Cell × Rubidium-82 × Clear all
NCT07346404 2026-01-16

RUBIKID

Assistance Publique - Hôpitaux de Paris

Phase 2 Not yet recruiting
50 enrolled
Genitourinary

Carcinoma, Renal Cell, Neovascularization, Pathologic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡